Edition:
United Kingdom

Eris Lifesciences Ltd (ERIS.NS)

ERIS.NS on National Stock Exchange of India

622.20INR
15 Feb 2019
Change (% chg)

Rs1.35 (+0.22%)
Prev Close
Rs620.85
Open
Rs625.05
Day's High
Rs634.30
Day's Low
Rs616.00
Volume
5,181
Avg. Vol
29,476
52-wk High
Rs849.00
52-wk Low
Rs572.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 15 Feb 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 5 5 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.71 1.71 1.71 1.71

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-19 6 10,400.70 10,814.00 10,154.20 12,162.00
Year Ending Mar-20 6 12,019.30 12,566.00 11,738.60 14,108.00
Earnings (per share)
Year Ending Mar-19 7 22.87 23.90 21.80 30.18
Year Ending Mar-20 7 28.03 29.27 25.68 33.78
LT Growth Rate (%) 1 14.80 14.80 14.80 25.31

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 2,489.23 2,523.95 34.72 1.40
Quarter Ending Sep-18 2,816.58 2,641.84 174.74 6.20
Quarter Ending Jun-18 2,500.00 2,507.61 7.61 0.30
Quarter Ending Mar-18 2,100.00 2,121.92 21.92 1.04
Quarter Ending Sep-17 2,200.00 2,492.34 292.34 13.29
Earnings (per share)
Quarter Ending Sep-18 6.21 6.20 0.01 0.16

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-19 10,400.70 10,400.70 10,670.70 10,646.30 12,162.00
Year Ending Mar-20 12,019.30 12,019.30 12,382.40 12,284.00 14,108.00
Earnings (per share)
Year Ending Mar-19 22.87 22.87 23.47 23.75 30.18
Year Ending Mar-20 28.03 28.03 29.20 29.20 33.78

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-19 0 0 0 2
Year Ending Mar-20 0 0 0 3
Earnings
Year Ending Mar-19 0 0 0 3
Year Ending Mar-20 0 0 0 5